EAN 2026 | The evolving concept of synucleinopathies in the era of biomarkers

Tiago Outeiro, PhD, University Medical Center Göttingen, Göttingen, Germany, discusses key insights from his presentation at EAN 2026 on the evolving concept of synucleinopathies in the era of biomarkers. Prof. Outeiro explains how advances in biomarker technologies are improving our understanding of the biological mechanisms underlying these disorders, enabling more accurate patient stratification and paving the way toward precision medicine. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.